BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 21452020)

  • 21. In vitro induction of benzo(a)pyrene diol epoxide-DNA adducts in peripheral lymphocytes as a susceptibility marker for human lung cancer.
    Li D; Wang M; Cheng L; Spitz MR; Hittelman WN; Wei Q
    Cancer Res; 1996 Aug; 56(16):3638-41. PubMed ID: 8705998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bulky DNA adducts as risk indicator of lung cancer in a Danish case-cohort study.
    Bak H; Autrup H; Thomsen BL; Tjønneland A; Overvad K; Vogel U; Raaschou-Nielsen O; Loft S
    Int J Cancer; 2006 Apr; 118(7):1618-22. PubMed ID: 16217769
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Risk assessment of environmental carcinogenesis using WBC DNA adducts].
    Ichiba M
    Nihon Eiseigaku Zasshi; 2004 Jul; 59(3):311-6. PubMed ID: 15359895
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC).
    Kaaks R; Berrino F; Key T; Rinaldi S; Dossus L; Biessy C; Secreto G; Amiano P; Bingham S; Boeing H; Bueno de Mesquita HB; Chang-Claude J; Clavel-Chapelon F; Fournier A; van Gils CH; Gonzalez CA; Gurrea AB; Critselis E; Khaw KT; Krogh V; Lahmann PH; Nagel G; Olsen A; Onland-Moret NC; Overvad K; Palli D; Panico S; Peeters P; Quirós JR; Roddam A; Thiebaut A; Tjønneland A; Chirlaque MD; Trichopoulou A; Trichopoulos D; Tumino R; Vineis P; Norat T; Ferrari P; Slimani N; Riboli E
    J Natl Cancer Inst; 2005 May; 97(10):755-65. PubMed ID: 15900045
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selection and validation of biomarkers for chemoprevention: the contribution of epidemiology.
    Vineis P; Veglia F
    IARC Sci Publ; 2001; 154():57-68. PubMed ID: 11220669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A population-based case-control study of the Arg399Gln polymorphism in DNA repair gene XRCC1 and risk of breast cancer.
    Shu XO; Cai Q; Gao YT; Wen W; Jin F; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1462-7. PubMed ID: 14693738
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aromatic DNA adducts and risk of gastrointestinal cancers: a case-cohort study within the EPIC-Spain.
    Agudo A; Peluso M; Munnia A; Luján-Barroso L; Sánchez MJ; Molina-Montes E; Sánchez-Cantalejo E; Navarro C; Tormo MJ; Chirlaque MD; Barricarte A; Ardanaz E; Amiano P; Dorronsoro M; Quirós JR; Piro S; Bonet C; Sala N; González CA
    Cancer Epidemiol Biomarkers Prev; 2012 Apr; 21(4):685-92. PubMed ID: 22315368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. White blood cell DNA adducts, smoking, and NAT2 and GSTM1 genotypes in bladder cancer: a case-control study.
    Peluso M; Airoldi L; Armelle M; Martone T; Coda R; Malaveille C; Giacomelli G; Terrone C; Casetta G; Vineis P
    Cancer Epidemiol Biomarkers Prev; 1998 Apr; 7(4):341-6. PubMed ID: 9568791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DNA adducts in tumour, normal peripheral lung and bronchus, and peripheral blood lymphocytes from smoking and non-smoking lung cancer patients: correlations between tissues and detection by 32P-postlabelling and immunoassay.
    Gyorffy E; Anna L; Gyori Z; Segesdi J; Minárovits J; Soltész I; Kostic S; Csekeo A; Poirier MC; Schoket B
    Carcinogenesis; 2004 Jul; 25(7):1201-9. PubMed ID: 15001535
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNA adducts in human breast tissue: association with N-acetyltransferase-2 (NAT2) and NAT1 genotypes.
    Pfau W; Stone EM; Brockstedt U; Carmichael PL; Marquardt H; Phillips DH
    Cancer Epidemiol Biomarkers Prev; 1998 Nov; 7(11):1019-25. PubMed ID: 9829711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination of DNA repair gene single nucleotide polymorphisms and increased levels of DNA adducts in a population-based study.
    Matullo G; Peluso M; Polidoro S; Guarrera S; Munnia A; Krogh V; Masala G; Berrino F; Panico S; Tumino R; Vineis P; Palli D
    Cancer Epidemiol Biomarkers Prev; 2003 Jul; 12(7):674-7. PubMed ID: 12869411
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytochrome P-450 and acetyltransferase expression as biomarkers of carcinogen-DNA adduct levels and human cancer susceptibility.
    Badawi AF; Stern SJ; Lang NP; Kadlubar FF
    Prog Clin Biol Res; 1996; 395():109-40. PubMed ID: 8895986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipid peroxidation-induced putative malondialdehyde-DNA adducts in human breast tissues.
    Wang M; Dhingra K; Hittelman WN; Liehr JG; de Andrade M; Li D
    Cancer Epidemiol Biomarkers Prev; 1996 Sep; 5(9):705-10. PubMed ID: 8877062
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between carcinogen-DNA adducts in white blood cells and lung cancer risk in the physicians health study.
    Tang D; Phillips DH; Stampfer M; Mooney LA; Hsu Y; Cho S; Tsai WY; Ma J; Cole KJ; Shé MN; Perera FP
    Cancer Res; 2001 Sep; 61(18):6708-12. PubMed ID: 11559540
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of diet on DNA bulky adduct levels are strongly modified by GSTM1 genotype: a study on 634 subjects.
    Palli D; Masala G; Peluso M; Gaspari L; Krogh V; Munnia A; Panico S; Saieva C; Tumino R; Vineis P; Garte S
    Carcinogenesis; 2004 Apr; 25(4):577-84. PubMed ID: 14656945
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation between biomarkers of human exposure to genotoxins with focus on carcinogen-DNA adducts.
    Gyorffy E; Anna L; Kovács K; Rudnai P; Schoket B
    Mutagenesis; 2008 Jan; 23(1):1-18. PubMed ID: 17989146
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bulky DNA adduct levels in normal-appearing colon mucosa, and the prevalence of colorectal adenomas.
    Ho V; Peacock S; Massey TE; Godschalk RW; van Schooten FJ; Ashbury JE; Vanner SJ; King WD
    Biomarkers; 2018 Dec; 23(8):735-741. PubMed ID: 29871536
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DNA adducts, DNA repair genotype/phenotype and cancer risk.
    Santella RM; Gammon M; Terry M; Senie R; Shen J; Kennedy D; Agrawal M; Faraglia B; Zhang F
    Mutat Res; 2005 Dec; 592(1-2):29-35. PubMed ID: 16023682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A prospective study of XRCC1 (X-ray cross-complementing group 1) polymorphisms and breast cancer risk.
    Patel AV; Calle EE; Pavluck AL; Feigelson HS; Thun MJ; Rodriguez C
    Breast Cancer Res; 2005; 7(6):R1168-73. PubMed ID: 16457697
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA adduct formation among workers in a Thai industrial estate and nearby residents.
    Peluso M; Srivatanakul P; Munnia A; Jedpiyawongse A; Meunier A; Sangrajrang S; Piro S; Ceppi M; Boffetta P
    Sci Total Environ; 2008 Jan; 389(2-3):283-8. PubMed ID: 17935758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.